Topic Hub
12 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 12 of 12 clinical reviews.
A complete caregiver guide to administering retatrutide subcutaneous injections in adolescents aged 12-17, covering injection technique, dose escalation, storage, missed doses, and safety monitoring.
Read clinical reviewA clinician-reviewed guide covering how retatrutide affects school performance, physical activity, sports participation, and daily scheduling for adolescents aged 12 to 17.
Read clinical reviewA comprehensive clinical guide for caregivers administering retatrutide to adults aged 65 and older, covering injection technique, dose escalation, monitoring for age-specific adverse effects, and when to contact a prescriber.
Read clinical reviewA clinical guide to managing retatrutide therapy during the adolescent-to-adult care transition, covering dose continuity, provider handoff, consent changes, and monitoring requirements for patients ages 12 to 17.
Read clinical reviewA clinician-reviewed guide to off-label retatrutide use in adolescents ages 12 to 17, covering the trial evidence, dosing rationale, safety signals, and guideline context as of 2025.
Read clinical reviewA clinical deep-dive into how retatrutide, the first triple GIP/GLP-1/glucagon receptor agonist, affects adults aged 65 and older, covering pharmacokinetics, muscle preservation, trial sub-group data, safety signals, and prescribing considerations for geriatric patients.
Read clinical reviewA clinician-focused guide to starting, adjusting, and monitoring retatrutide in patients aged 65 and older, covering dose titration, sarcopenia risk, organ-function considerations, and care-transition protocols.
Read clinical reviewA clinical overview of retatrutide's evidence base, pharmacology, and off-label status in pediatric patients under age 12, reviewed by the HealthRX medical team.
Read clinical reviewA clinical guide to managing retatrutide therapy continuity when children under 12 transition from pediatric to adult endocrinology care, including current evidence, safety considerations, and practical handoff protocols.
Read clinical reviewA clinical review of retatrutide's potential developmental impact in children under 12, covering GIP/GLP-1/glucagon receptor pharmacology, growth axis concerns, bone and neurodevelopmental safety, and why no pediatric trials exist yet.
Read clinical reviewA clinician-reviewed guide for caregivers administering retatrutide to children under age 12, covering current evidence, safety considerations, injection technique, dose-escalation protocols, and when to call the prescribing team.
Read clinical reviewA clinical guide covering how retatrutide may affect school performance, physical activity, nutrition, and daily routines in children under 12, including dosing context, safety signals, and practical management strategies.
Read clinical review